MyFinsight
Home
About
Contact
crdf: the income statement
Download
Download image
Net loss
attributable to common...
-$11,264K
(5.03%↑ Y/Y)
Interest income, net
$716K
(-3.37%↓ Y/Y)
Preferred stock dividend
payable on series a...
$6K
(0.00%↑ Y/Y)
Net loss
-$11,258K
(5.04%↑ Y/Y)
Total other income
(expense), net
$716K
(-4.02%↓ Y/Y)
Loss from operations
-$11,974K
(4.98%↑ Y/Y)
Royalty revenues
$120K
(-27.27%↓ Y/Y)
Total operating
expenses
$12,094K
(-5.26%↓ Y/Y)
Selling, general and
administrative
$3,897K
(24.66%↑ Y/Y)
Research and development
$8,197K
(-14.97%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF)